Finesse Solutions Expands by Opening Sales and Service Centers

March 7, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the opening of its new sales and service center in Northborough, MA, in order to support its east coast customer base. Additionally, Finesse Solutions is converting its Irvine, CA facility to a service center for its west coast customer base. The company also plans on opening a European sales and service center in the summer of 2008, and additional sales and service centers in the U.S. by the end of 2008.

“We are delighted to be able to extend a faster and more effective response to our customers and partners” said John O’Connell, VP Sales and Business Development for Finesse. “Industry acceptance and customer demand has been growing very quickly for our solutions. The opening of the Northborough office is the first step in our expansion plans to better serve and support our east coast and international customers.”

In addition to these new service centers, the Santa Clara headquarters facility will expand its software, hardware and sensor development activities. All development work will be unified at the Silicon Valley headquarters in order to exploit the synergies between these different disciplines and create better integrated measurement and control solutions.

“Solidifying our development efforts under one roof will enable our scientists and engineers to create even better plug-and-play sensor and automation solutions” stated Dr. Barbara Paldus, CEO of Finesse.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family

provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

< | >